company background image
BLAU3

Blau Farmacêutica BOVESPA:BLAU3 Stock Report

Last Price

R$16.04

Market Cap

R$2.8b

7D

-4.2%

1Y

-44.0%

Updated

26 Nov, 2023

Data

Company Financials +

BLAU3 Stock Overview

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay.

BLAU3 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Blau Farmacêutica S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Blau Farmacêutica
Historical stock prices
Current Share PriceR$16.04
52 Week HighR$31.48
52 Week LowR$14.18
Beta0.17
1 Month Change-0.93%
3 Month Change-9.22%
1 Year Change-44.01%
3 Year Changen/a
5 Year Changen/a
Change since IPO-60.97%

Recent News & Updates

Recent updates

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Shareholder Returns

BLAU3BR BiotechsBR Market
7D-4.2%0.6%-0.4%
1Y-44.0%-8.1%6.7%

Return vs Industry: BLAU3 underperformed the BR Biotechs industry which returned -8.1% over the past year.

Return vs Market: BLAU3 underperformed the BR Market which returned 6.5% over the past year.

Price Volatility

Is BLAU3's price volatile compared to industry and market?
BLAU3 volatility
BLAU3 Average Weekly Movement7.0%
Biotechs Industry Average Movement9.0%
Market Average Movement5.2%
10% most volatile stocks in BR Market8.9%
10% least volatile stocks in BR Market2.6%

Stable Share Price: BLAU3 is more volatile than 75% of BR stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: BLAU3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.

About the Company

FoundedEmployeesCEOWebsite
1987n/aMarcelo Hahnhttps://www.blau.com

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company’s medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets.

Blau Farmacêutica S.A. Fundamentals Summary

How do Blau Farmacêutica's earnings and revenue compare to its market cap?
BLAU3 fundamental statistics
Market CapR$2.85b
Earnings (TTM)R$317.12m
Revenue (TTM)R$1.35b

9.0x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BLAU3 income statement (TTM)
RevenueR$1.35b
Cost of RevenueR$819.77m
Gross ProfitR$532.08m
Other ExpensesR$214.97m
EarningsR$317.12m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.78
Gross Margin39.36%
Net Profit Margin23.46%
Debt/Equity Ratio28.7%

How did BLAU3 perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

10%

Payout Ratio